Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2006-06-13
2006-06-13
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S465000, C514S229800, C514S230500
Reexamination Certificate
active
07060294
ABSTRACT:
This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.
REFERENCES:
patent: 5260073 (1993-11-01), Phipps
patent: 5519021 (1996-05-01), Young et al.
patent: 5663169 (1997-09-01), Young et al.
patent: 5665720 (1997-09-01), Young et al.
patent: 5856492 (1999-01-01), Chen et al.
patent: 5874430 (1999-02-01), Christ et al.
patent: 5922864 (1999-07-01), Frey et al.
patent: 5965729 (1999-10-01), Clarke et al.
patent: 5998625 (1999-12-01), Tillyer et al.
patent: 6180634 (2001-01-01), Vacca et al.
patent: 6238695 (2001-05-01), Makooi-Morehead et al.
patent: 0 384 600 (1990-08-01), None
patent: 0 547 000 (1993-06-01), None
patent: WO 94/03440 (1994-02-01), None
patent: WO 95/20389 (1995-08-01), None
patent: WO 96/37457 (1996-11-01), None
patent: WO 98/30543 (1998-07-01), None
patent: WO 98/33782 (1998-08-01), None
patent: WO 98/52570 (1998-11-01), None
patent: WO 99/51239 (1999-10-01), None
patent: WO 96/22955 (2003-08-01), None
Michael Aulton et al, Chapter 25, Granualtion, pp. 365-378, at p. 366 last para. See http://fleshandbones.com/readingroom/pdf/473.pdf, last visited May 22, 2004.
Thompson et al., “Use of an Ephedrine Alkoxide to Mediate Enantioselective Addition of an Ecetylide to a Prochiral Ketone: Asymmetric Synthesis of the Reverse Transcriptase Inhibitor L-743,726”, Tetrahedron Letters, vol. 36, pp. 8937-8940 (1995).
Remington: The Science and Practice of Pharmacy, 19th Edition, vol. II, pp. 1616-1620 (1995).
“Los Inhibidores de La Proteasa Del VIH-I”, 1997, http://www.prevanir.com/salud/sida/inhibid-proteasa.html.
“Tratamiento con Antirretrovirales”, 1997, http://www.prevenir.com/salud/sida/tratamiento.html.
Remington's Pharmaceutical Sciences, 1995, pp. 859-869.
L.M. Prescott, “Antimicrobial Agents and Chemotherapy”, 1997, vol. X, No. 12.
Batra Udit
Higgins Raymond J.
Katdare Ashok V.
Thompson Karen C.
Camara Valerie J.
Merck & Co. Inc
Padmanabhan Sreeni
Sharareh Shahnam
Walton Kenneth R.
LandOfFree
Compressed tablet formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compressed tablet formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compressed tablet formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3677928